Oncolytics Biotech Inc Strategic Asset Allocation Index
Oncolytics Biotech Inc strategic asset allocation index. Oncolytics Biotech Inc (ONC) has a Strategic Asset Allocation Index of 18.7% as of March 2025. Strategic assets (PP&E of CA$1.22 Million plus long-term investments of CA$-) total CA$1.22 Million, measured against net assets of CA$6.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Oncolytics Biotech Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Oncolytics Biotech Inc (2013–2024)
Strategic asset allocation index of Oncolytics Biotech Inc from 2013 to 2024. This chart shows how Oncolytics Biotech Inc's Strategic Asset Allocation Index has evolved across 11 annual periods from 2013 to 2024. As of March 2025, the index stands at 18.7%, representing strategic assets of CA$1.22 Million against net assets of CA$6.49 Million CAD. Check ONC intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Oncolytics Biotech Inc Strategic Asset Allocation Index by Year (2013–2024)
Oncolytics Biotech Inc strategic asset allocation index by year from 2013 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Oncolytics Biotech Inc from 2013 to 2024, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Oncolytics Biotech Inc.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 21.9% | CA$1.31 Million | CA$1.31 Million | CA$- | CA$5.98 Million | ▲ +19.6 pp |
| 2023 | 2.3% | CA$647.00K | CA$647.00K | CA$- | CA$27.56 Million | ▼ -0.1 pp |
| 2022 | 2.5% | CA$652.00K | CA$652.00K | CA$- | CA$26.50 Million | ▼ -0.2 pp |
| 2021 | 2.7% | CA$976.29K | CA$976.29K | CA$- | CA$36.10 Million | ▲ +0.2 pp |
| 2020 | 2.5% | CA$609.13K | CA$609.13K | CA$- | CA$24.75 Million | ▼ -4.2 pp |
| 2018 | 6.7% | CA$412.74K | CA$412.74K | CA$- | CA$6.20 Million | ▲ +2.6 pp |
| 2017 | 4.0% | CA$333.44K | CA$333.44K | CA$- | CA$8.28 Million | ▲ +1.0 pp |
| 2016 | 3.0% | CA$319.95K | CA$319.95K | CA$- | CA$10.69 Million | ▲ +1.1 pp |
| 2015 | 1.9% | CA$459.82K | CA$459.82K | CA$- | CA$24.67 Million | ▼ -1.9 pp |
| 2014 | 3.8% | CA$525.38K | CA$525.38K | CA$- | CA$13.82 Million | ▲ +1.4 pp |
| 2013 | 2.4% | CA$532.46K | CA$532.46K | CA$- | CA$22.21 Million | — |